Pharmaceutical Contract Sales Organizations Market To Reach $23.8 Billion By 2033

Pharmaceutical Contract Sales Organizations Market Growth & Trends

The global pharmaceutical contract sales organizations market size is expected to reach USD 23.8 billion by 2033, registering a CAGR of 9.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. High adoption of new technologies for contract sales by pharmaceutical contract sales organizations (CSO), an increase in the interest among end-users to increase the sales of biopharmaceutical and small molecule drugs, and the surge in demand for reducing the cost associated with in-house sales are some of the key factors supporting the growth of the industry. Over the years, the number of new drug launches has increased.

For instance, according to the IQVIA report on R&D trends, 84 new active substances were launched globally in 2021, which was double as compared to the last five years. The increase in drug launches globally is expected to improve the demand for contract sales services, which is likely to support industry growth. Prescription drug sales are witnessing a steady rise. For instance, according to Evaluate Pharma, worldwide total prescription drug sales accounted for USD 1,066 billion in 2021 and will reach USD 1,612 billion by 2028. The growing demand for sales among pharmaceutical companies is expected to improve the demand for CSO services for pharmaceuticals in the post-pandemic period.

 Request a free sample copy or view the report summary: Pharmaceutical Contract Sales Organizations Market Report

Pharmaceutical Contract Sales Organizations Market Report Highlights

• The personal promotion segment led the market with the largest revenue share of 59.5% in 2025. The growth is driven by increasing investment by pharmaceutical companies in R&D, making commercial marketing crucial to overall revenue growth.

• The oncology segment led the market with the largest revenue share of 32.8% in 2025. According to January 2026 estimates, the U.S. is expected to record approximately 2,114,850 new cancer diagnoses and 626,140 cancer deaths. Thus, the rising cancer burden in the U.S. continues to accelerate demand for specialized pharmaceutical commercialization services, strengthening growth opportunities for pharmaceutical contract sales organizations.

• The pharmaceutical companies segment led the market with the largest revenue share of 53.1% in 2025. The market growth is driven by increasing demand for cost-effective sales solutions, expanding drug pipelines, and rising commercialization efforts.

• North America dominated the global pharmaceutical contract sales organizations market with the largest revenue share of 37.9% in 2025. This can be attributed to the strong presence of major pharmaceutical and biopharmaceutical companies, high healthcare expenditures, and advanced commercialization strategies.

Pharmaceutical Contract Sales Organizations Market Segmentation

Grand View Research has segmented the global pharmaceutical contract sales organizations market on the basis of service, therapeutic area, end use, and region:

Pharmaceutical Contract Sales Organizations Service Outlook (Revenue, USD Billion, 2021 - 2033)

• Personal Promotion

  • Promotional sales team

  • Key account management

  • Vacancy Management

• Non-personal promotion

  • Medical affairs solutions

  • Remote medical science liaisons

  • Nurse educators

  • Others

Pharmaceutical Contract Sales Organizations Therapeutic Area Outlook (Revenue, USD Billion, 2021 - 2033)

• Oncology

• Cardiovascular

• Neurology

• Infectious Diseases

• Metabolic Disorders

• Orthopedic Diseases

• Others

Pharmaceutical Contract Sales Organizations End Use Outlook (Revenue, USD Billion, 2021 - 2033)

• Pharmaceutical Companies

• Biopharmaceutical Companies

Pharmaceutical Contract Sales Organizations Regional Outlook (Revenue, USD Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List of Key Players in Pharmaceutical Contract Sales Organizations Market

• CMIC Holdings Co., Ltd.

• Axxelus

• EPS Corp.

• QFR Solutions

• MaBico

• Mednext Pharma Pvt. Ltd.

• Peak Pharma Solutions Inc.

• IQVIA, Inc.

• Promoveo Health

• Syneous Health